查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1938837

血壓監測設備市場－全球產業規模、佔有率、趨勢、機會及預測（依產品類型、技術、最終用戶、地區及競爭格局分類，2021-2031年）

Blood Pressure Monitoring Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Technology, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球血壓監測設備市場預計將從 2025 年的 28.2 億美元成長到 2031 年的 43.5 億美元，複合年成長率為 7.49%。

這些診斷設備涵蓋了從手動血壓計到自動數位血壓計等各種類型，既可用於醫療用途，也可用於個人，其設計目的都是為了測量動脈血壓。推動該市場成長的因素有二：一是全球慢性心血管疾病盛行率不斷上升，二是人口老化速度加快，這兩方面都要求人們頻繁進行健康評估，以預防急性醫療事件的發生。例如，世界衛生組織（WHO）估計，到2024年，全球將有14億30至79歲的成年人患有高血壓，凸顯了對有效檢測工具的巨大需求。

市場概覽
預測期 2027-2031
市場規模：2025年 28.2億美元
市場規模：2031年 43.5億美元
複合年成長率：2026-2031年 7.49%
成長最快的細分市場 電子血壓計
最大的市場 亞太地區

然而，阻礙市場發展的一大障礙是，在非受控臨床環境下使用的自動血壓監測儀的準確性存在差異。這些測量結果與專業標準之間的差異可能導致誤診，並削弱醫療專業人員對患者自述數據的信任。此外，遵守複雜的監管核准流程以及滿足不同國際司法管轄區的嚴格檢驗標準也構成了巨大的准入門檻，最終將減緩經濟實惠的監測解決方案的廣泛應用。

市場促進因素

全球高血壓和心血管疾病盛行率的不斷上升是血壓監測設備市場的主要驅動力。這種激增與肥胖和缺乏運動等生活方式相關的風險因素密切相關，從而推動了臨床和家庭環境中對精準診斷工具的需求。隨著慢性病負擔的加重，醫療保健系統更加重視早期發現和持續管理，以降低中風和心臟衰竭等嚴重後果的發生率。根據美國心臟協會於2024年1月發布的《2024年心臟病和中風統計數據》的重點內容，美國約有1.224億成年人患有高血壓，這凸顯了為不斷成長的患者群體提供廣泛可用的監測解決方案的迫切需求。

同時，遠端患者監護（RPM）和遠端醫療基礎設施的成長正在改變市場動態，將醫療保健從醫院轉移到個人場所。無線數據傳輸技術整合到監護設備中，使醫生能夠即時追蹤患者的生命徵象並主動調整治療方案，從而推動了這一趨勢。此類數位健康工具的應用正成為現代醫療實踐的結構性組成部分。根據美國醫學會（AMA）於2024年1月發布的《2024年數位健康調查》，20.3%的醫師表示使用遠端患者監護工具，是2018年的兩倍。這種向互聯醫療的轉變也體現在全球分銷量上。Omron Corporation在2024年9月發布的《2024年綜合報告》中指出，2023會計年度全球血壓計銷售量達2,246萬台。

市場挑戰

在非受控臨床環境下使用的自動血壓監測儀的準確性存在差異，這是血壓測量設備市場擴張的主要障礙。當個人監測設備讀數與專家基準值不一致時，醫療專業人員會對患者自測資料的可靠性產生嚴重擔憂，進而影響診斷決策。這種疑慮直接降低了醫療專業人員開立或建議家用血壓監測方案的意願，從而阻礙了這些技術的廣泛應用。

根據美國醫學會 (AMA) 2024 年的數據，美國主要電商平台上銷售的血壓計中，約有 80% 未經臨床檢驗。如此高的未經檢驗率削弱了消費者的信任，並造成了市場分散，使得值得信賴的認證製造商難以與低品質的替代品競爭。因此，零售產品測量準確性的一致性無法保證，限制了市場將其全面融入標準慢性病管理通訊協定的能力，並阻礙了合規製造商的收入成長。

市場趨勢

無袖帶穿戴式生物辨識技術的出現正在革新市場，它無需傳統充氣袖帶帶來的不適感，即可實現連續、非侵入性的血壓監測。這些設備利用光學感測器和專有演算法測量手腕或手指的訊號，提供全天候數據，包括夜間血壓下降和波動，而這些往往是間歇性測量所無法捕捉到的。這項創新解決了患者依從性這一關鍵難題，其被動式設計鼓勵用戶持續佩戴，並產生縱向資料集，從而實現更精準的高血壓管理。根據 Fit Insider 2025 年 5 月發表的題為「Aktiia 為下一代血壓技術籌集 4,200 萬美元」的報導報道，瑞士製造商 Hilo（前身為 Aktiia）已在全球 40 多個國家/地區售出超過 12 萬台無袖帶血壓計，這表明該光學測量解決方案具有商業性可行性，且消費者需求日益成長。

此外，人工智慧 (AI) 在預測性高血壓分析中的應用，正將設備從單純的測量工具轉變為全面的心血管風險評估平台。製造商正將機器學習演算法直接整合到監測系統中，以分析血壓脈搏波的異常情況，從而在標準血壓測量的基礎上，早期發現諸如房顫等合併症。這項技術進步為患者和醫生提供了可操作的見解，有助於在急性心血管事件發生前進行主動干預。根據Omron Healthcare於 2025 年 5 月發布的新聞稿《Omron Healthcare利用人工智慧驅動的房顫檢測技術革新血壓測量體驗》，該公司新型監測儀中的 IntelliSense 人工智慧算法在臨床試驗中檢測房顫的靈敏度達到 95%，特異性達到 98%，為家用診斷的準確度樹立了新的標準準確性。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球血壓監測設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（數位血壓計、血壓計、感測器、其他）
    • 按技術（數位、安卓、穿戴式裝置）
    • 按最終使用者（醫院/診所、門診手術中心、居家醫療、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美血壓監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章 歐洲血壓監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區血壓監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章 中東和非洲血壓監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章 南美洲血壓監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球血壓監測設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Omron Corporation
  • A&D Medical Inc.
  • Philips Healthcare
  • Hillrom, Inc.
  • General Electric Company
  • Panasonic Corporation
  • Microlife Corporation
  • Beurer GmbH
  • SunTech Medical, Inc.
  • iHealth Labs, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7320

The Global Blood Pressure Monitoring Devices Market is projected to expand from a valuation of USD 2.82 Billion in 2025 to USD 4.35 Billion by 2031, reflecting a compound annual growth rate of 7.49%. These diagnostic instruments, which include manual sphygmomanometers and automated digital systems for both professional and personal use, are designed to measure arterial pressure. The market is fundamentally underpinned by the escalating global prevalence of chronic cardiovascular conditions and a rapidly aging population, both of which necessitate frequent health assessments to prevent acute medical incidents. For instance, the World Health Organization estimated in 2024 that 1.4 billion adults aged 30 to 79 years worldwide were living with hypertension, emphasizing the critical demand for effective detection tools.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.82 Billion
Market Size 2031USD 4.35 Billion
CAGR 2026-20317.49%
Fastest Growing SegmentDigital Blood Pressure Monitor
Largest MarketAsia Pacific

However, a significant obstacle that could hinder market progression involves the accuracy variances observed in automated monitors utilized outside of controlled clinical environments. Discrepancies between these readings and professional standards can lead to incorrect diagnoses and diminish trust among healthcare providers regarding patient-generated data. Furthermore, navigating complex regulatory approval pathways and adhering to stringent validation standards across various international jurisdictions presents substantial barriers to entry, ultimately delaying the distribution of affordable monitoring solutions.

Market Driver

The increasing global prevalence of hypertension and cardiovascular diseases serves as a primary catalyst driving the blood pressure monitoring devices market. This surge is closely tied to lifestyle-related risk factors, such as obesity and sedentary behavior, which are intensifying the demand for accurate diagnostic tools in both clinical and home settings. As the burden of chronic conditions grows, healthcare systems are prioritizing early detection and consistent management to mitigate severe outcomes like stroke and heart failure. Highlights from the American Heart Association's "Heart Disease and Stroke Statistics-2024 Update" in January 2024 reveal that approximately 122.4 million adults in the United States had high blood pressure, underscoring the critical need for widely accessible monitoring solutions to address this expanding patient pool.

Simultaneously, the growth of remote patient monitoring (RPM) and telehealth infrastructure is reshaping market dynamics by transitioning care from hospitals to personal environments. This driver is supported by the integration of wireless data transmission in monitoring devices, enabling physicians to track patient vitals in real-time and adjust treatments proactively. The adoption of these digital health tools has become a structural component of modern medical practice; the American Medical Association's "2024 Digital Health Study" in January 2024 noted that 20.3 percent of physicians reported using remote patient monitoring tools, twice the rate observed in 2018. This shift toward connected care is reflected in global distribution volumes, with Omron Corporation reporting in September 2024, via their "Integrated Report 2024," global sales of 22.46 million blood pressure monitors for fiscal year 2023.

Market Challenge

Accuracy variances found in automated monitors used outside controlled clinical environments constitute a primary obstacle to the expansion of the blood pressure monitoring devices market. When personal monitoring devices produce inconsistent readings compared to professional references, it creates significant hesitation among healthcare practitioners regarding the reliability of patient-generated data for diagnostic decisions. This skepticism directly reduces the willingness of medical professionals to prescribe or recommend home monitoring solutions, thereby stifling the broader adoption of these technologies.

According to 2024 data from the American Medical Association, approximately 80 percent of blood pressure devices sold through major e-commerce sites in the United States had not been clinically validated for accuracy. Such high rates of non-validation undermine consumer confidence and create a fractured market environment where reliable, certified manufacturers struggle to compete against lower-quality alternatives. Consequently, the inability to guarantee consistent measurement precision across all retail products limits the market's potential to fully integrate into standard chronic disease management protocols and impedes revenue growth for compliant manufacturers.

Market Trends

The emergence of cuffless wearable bio-sensing technologies is revolutionizing the market by enabling continuous, non-invasive blood pressure tracking without the discomfort of traditional inflatable cuffs. These devices utilize optical sensors and proprietary algorithms to measure signals from the wrist or finger, providing 24/7 data that captures nocturnal dips and variability often missed by sporadic spot-checks. This shift addresses the critical issue of patient compliance, as the passive nature of the technology encourages sustained usage and generates longitudinal data sets for more accurate hypertension management. As reported by Fitt Insider in May 2025, in the article "Aktiia Scores $42M for Next-Gen Blood Pressure Tech," Swiss manufacturer Hilo (formerly Aktiia) has successfully sold over 120,000 cuffless monitoring devices across 40 countries, validating the growing commercial viability and consumer demand for these optical measurement solutions.

Furthermore, the integration of artificial intelligence for predictive hypertension analytics is transforming devices from simple measurement tools into comprehensive cardiovascular risk assessment platforms. Manufacturers are embedding machine learning algorithms directly into monitoring systems to analyze pressure pulse waves for irregularities, allowing for the early detection of comorbidities such as atrial fibrillation alongside standard blood pressure readings. This technological advancement empowers patients and physicians with actionable insights, facilitating proactive interventions before acute cardiac events occur. According to OMRON Healthcare's May 2025 press release, "OMRON Healthcare Evolves the Blood Pressuring Experience with AI-powered AFib detection," their new monitors featuring the IntelliSense AI algorithm demonstrated a 95 percent sensitivity and 98 percent specificity for detecting atrial fibrillation in clinical studies, establishing a new standard for home-based diagnostic accuracy.

Key Market Players

  • Omron Corporation
  • A&D Medical Inc.
  • Philips Healthcare
  • Hillrom, Inc.
  • General Electric Company
  • Panasonic Corporation
  • Microlife Corporation
  • Beurer GmbH
  • SunTech Medical, Inc.
  • iHealth Labs, Inc.

Report Scope

In this report, the Global Blood Pressure Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Pressure Monitoring Devices Market, By Product Type

  • Digital Blood Pressure Monitor
  • Sphygmomanometer
  • Transducers
  • Others

Blood Pressure Monitoring Devices Market, By Technology

  • Digital
  • Android
  • Wearable

Blood Pressure Monitoring Devices Market, By End User

  • Hospitals & Clinics
  • Ambulatory Surgery Centres
  • Home Care
  • Others

Blood Pressure Monitoring Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Pressure Monitoring Devices Market.

Available Customizations:

Global Blood Pressure Monitoring Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Pressure Monitoring Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Digital Blood Pressure Monitor, Sphygmomanometer, Transducers, Others)
    • 5.2.2. By Technology (Digital, Android, Wearable)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centres, Home Care, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Blood Pressure Monitoring Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Technology
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood Pressure Monitoring Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Blood Pressure Monitoring Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Blood Pressure Monitoring Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By End User

7. Europe Blood Pressure Monitoring Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Technology
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Blood Pressure Monitoring Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By End User
    • 7.3.2. France Blood Pressure Monitoring Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Blood Pressure Monitoring Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Blood Pressure Monitoring Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Blood Pressure Monitoring Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By End User

8. Asia Pacific Blood Pressure Monitoring Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Technology
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Blood Pressure Monitoring Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By End User
    • 8.3.2. India Blood Pressure Monitoring Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Blood Pressure Monitoring Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Blood Pressure Monitoring Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Blood Pressure Monitoring Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By End User

9. Middle East & Africa Blood Pressure Monitoring Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Technology
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Blood Pressure Monitoring Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Blood Pressure Monitoring Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Blood Pressure Monitoring Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By End User

10. South America Blood Pressure Monitoring Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Technology
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Blood Pressure Monitoring Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Blood Pressure Monitoring Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Blood Pressure Monitoring Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Blood Pressure Monitoring Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Omron Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. A&D Medical Inc.
  • 15.3. Philips Healthcare
  • 15.4. Hillrom, Inc.
  • 15.5. General Electric Company
  • 15.6. Panasonic Corporation
  • 15.7. Microlife Corporation
  • 15.8. Beurer GmbH
  • 15.9. SunTech Medical, Inc.
  • 15.10. iHealth Labs, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer